Medical Cannabis Significantly Safer for Elderly With Chronic Pain Than Opioids, According to Ben-Gurion University of the Negev Researchers
Medical cannabis therapy can significantly reduce chronic pain in patients age 65 and older without adverse effects, according to researchers at Ben-Gurion University of the Negev (BGU) and the Cannabis Clinical Research Institute at Soroka University Medical Center.
The new study, published in The European Journal of Internal Medicine, found cannabis therapy is safe and efficacious for elderly patients who are seeking to address cancer symptoms, Parkinson’s disease, post-traumatic stress disorder, ulcerative colitis, Crohn’s disease, multiple sclerosis, and other medical issues.
“While older patients represent a large and growing population of medical cannabis users, few studies have addressed how it affects this particular group, which also suffers from dementia, frequent falls, mobility problems, and hearing and visual impairments,” says Prof. Victor Novack, M.D., a professor of medicine in the BGU Faculty of Health Sciences (FOHS), and head of the Soroka Cannabis Clinical Research Institute. Novack is also the BGU Gussie Krupp Chair in Internal Medicine.
“After monitoring patients 65 and older for six months, we found medical cannabis treatment significantly relieves pain and improves quality of life for seniors with minimal side effects reported.”
This older population represents a growing segment of medical cannabis users, ranging from approximately seven percent to more than 33 percent, depending on the country. Recent U.S. polls indicate Americans over 65 represent 14 percent of the total population and use more than 30 percent of all prescription drugs, including highly addictive painkillers.
BGU researchers surveyed 2,736 patients 65 years and older who received medical cannabis through “Tikun Olam,” the largest Israeli medical cannabis supplier. More than 60 percent were prescribed medical cannabis due to the pain, particularly pain associated with cancer. After six months of treatment, more than 93 percent of 901 respondents reported their pain dropped from a median of eight to four on a 10-point scale. Close to 60 percent of patients who originally reported “bad” or “very bad” quality of life upgraded to “good” or “very good” after six months. More than 70 percent of patients surveyed reported moderate to significant improvement in their condition.
The most commonly reported adverse effects were dizziness (9.7 percent) and dry mouth (7.1 percent). After six months, more than 18 percent of patients surveyed had stopped using opioid analgesics or had reduced their dosage.
All patients received a prescription after consulting with a doctor who prescribed treatment. More than 33 percent of patients used cannabis-infused oil; approximately 24 percent inhaled therapy by smoking, and approximately six percent used vaporization.
While the researchers state their findings to date indicate cannabis may decrease dependence on prescription medicines, including opioids, more evidence-based data from this special, aging population is imperative.
The Latest on: Medical cannabis therapy
- Parents discuss how medical cannabis oil helps their kids on November 12, 2018 at 8:03 pm
Previously, doctors could only suggest it as a treatment for epilepsy ... a registered nurse and advocate for medical cannabis. She said she’s found numerous studies backing this up. […]
- Verify: Does legalizing marijuana have an effect on the opioid crisis? on November 12, 2018 at 1:21 pm
That includes more research on medical marijuana’s impact on chronic pain ... such as over over-the-counter drugs like ibuprofen or alternative treatments like occupational therapy.&rdquo […]
- Crohn's & Colitis Foundation Review of the Role of Medical Cannabis in the Management of Crohn's and Colitis Published in IBD Journal on November 12, 2018 at 12:12 pm
NEW YORK, Nov. 12, 2018 /PRNewswire/ -- A white paper written by Crohn's & Colitis Foundation scientific advisors and staff examining the clinical, scientific, and regulatory landscape as it pertains ... […]
- Connecticut adds 31st condition to medical marijuana program on November 12, 2018 at 8:22 am
A new condition can now be treated with medical marijuana in Connecticut. The General Assembly’s Regulations Review Committee has agreed that chronic neuropathic pain associated with degenerative spin... […]
- What Pa. patients are treating with their medical marijuana on November 12, 2018 at 5:42 am
Medical marijuana patients in Pennsylvania are using cannabis to ... MS, and opiate-substitution therapy. “The most common recommendation we write is for oral preparations such as capsules, tinctures, ... […]
- Curaleaf Opens Its 15th Medical Marijuana Dispensary in Florida on November 12, 2018 at 4:30 am
"Since the time Florida's voters approved medical marijuana in the state, our team at Curaleaf has been dedicated to ensuring patients have access to this life-changing treatment," said Curaleaf Flori... […]
- Will Michigan law push Indiana toward cannabis? on November 11, 2018 at 3:22 am
He said he’s determined to bring medical and maybe recreational marijuana to Indiana. “I used to be indifferent,” Lucas said. Then within the past couple of years he began reading up on CBD oil for se... […]
- Marijuana foe Jeff Sessions is out, but is that a good thing? on November 10, 2018 at 10:59 pm
He has encouraged the president to speak out about it and chided him for the lax treatment and comments on marijuana ... They sent a clear message to Sessions to keep his hands off marijuana, its medi... […]
- The Green Option: Marijuana use rises among American Baby Boomers on November 9, 2018 at 2:35 pm
He said two years ago while he was living in Colorado, where medical marijuana is legal, he switched to the alternative medical treatment. Since then, he said he is a much healthier man compared to hi... […]
- In the News: 3 States Adopt New Cannabis Laws; AG Sessions Resigns on November 9, 2018 at 2:27 pm
Medical marijuana sales are exempt from state and local sales taxes ... at the request of President Trump. Sessions’ treatment of the cannabis industry was marked by his repeal of the Cole Memorandum, ... […]
via Google News and Bing News